Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie 04. Novembre 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Troubles de la motilité
Néoplasie
Autres
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 2002  Page précédente Page suivante
   
   Articles 1 - 20 / 40028  
   
From presumed metastasis to infection: coccidioidomycosis mimicking metastatic gastroesophageal adenocarcinoma.
Rev Gastroenterol Peru
Diaz Fernandez W, Leggett C.
PMID: 42977282 [PubMed - indexed for MEDLINE]


Clinical Outcomes and Prognostic Factors in Driver-Negative Stage IV Non-small Cell Lung Cancer Patients Receiving Thoracic Radiotherapy: A Single-Center Retrospective Study.
Technol Cancer Res Treat
Shang C, Yang J, Wang M, Peng N, Yang B, Wang G, Li H, Tan S, Fang Q, Yang M, Xia Y.
PMID: 42975949 [PubMed - indexed for MEDLINE]


Can Esophagectomy be Safely Avoided After Clinical Complete Response in Esophageal Squamous Cell Carcinoma? Response Assessment, Active Surveillance, and Salvage in the Immunotherapy Era.
Curr Oncol Rep
Sagawa T, Hirakawa M, Nagashima H, Fujikawa K.
PMID: 42975733 [PubMed - indexed for MEDLINE]


Oncologic efficacy and safety of stereotactic body radiotherapy for oligometastatic non-small cell lung cancer: a systemic meta-analysis.
Clin Exp Metastasis
Jeong JU, Yoo GS, Lee JH, Chan Ahn Y, Rim CH, Chie EK, Chang AR, Korean Cancer Association Oligometastasis Working Group.
PMID: 42975717 [PubMed - indexed for MEDLINE]


Coronary artery calcification is not associated with survival in advanced gastric and gastroesophageal junction cancer: a secondary analysis of the EXPAND trial.
J Cancer Res Clin Oncol
Meyer HJ, Dermendzhiev T, Jacobs PP, Romeo D, Stocker G, Denecke T, Lordick F, Hacker UT.
PMID: 42975671 [PubMed - indexed for MEDLINE]


Leptomeningeal carcinomatosis arising from esophageal cancer: a systematic review of the literature.
Dis Esophagus
Mylonakis A, Stylios D, Tsilimigras D, Charalampopoulos G, Kotsantis I, Liontos M, Georgakopoulos I, Schizas D.
PMID: 42974869 [PubMed - indexed for MEDLINE]


Efficacy and safety analysis of consolidation immunotherapy following definitive concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Front Immunol
Liu W, Zhu Q, Xu S, Chen J, Wang D, Wu T, Shen J, Zhu Y, Chen Z, Liu Y, Wang G, Wu C, Wang Y.
PMID: 42973545 [PubMed - indexed for MEDLINE]


Are non-cancer diagnoses missed opportunities in diagnosing cancer? Observational case-control studies.
Br J Gen Pract
Price S, Abel GA, Black G, Friedemann Smith C, Hamilton W, King A, Laity G, Lavu D, Moore SF, Mounce LTA, Nansubuga E, Nicholson BD, Ramasawmy M, Robles L, Scott S, Spencer A, Walter FM, Wiering B, Neal R.
PMID: 42971713 [PubMed - as supplied by publisher]


High-dose reirradiation of in-field recurrence lung cancer in the THOrax (RETHO): toxicity analysis of a prospective trial.
Int J Radiat Oncol Biol Phys
Duijm DM, Cammareri E, Granton DPV, Schillemans W, Petit DS, Belderbos DJ, van Werkhoven DE, Cornelissen DR, Knegjens JL, Nuyttens DJJ.
PMID: 42971440 [PubMed - as supplied by publisher]


Salvage esophagectomy versus photodynamic therapy for localized residual or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy or radiotherapy: a single-center comparative study.
J Gastroenterol
Ujiie N, Sato C, Taniyama Y, Okamoto H, Ozawa Y, Ishida H, Unno M, Kamei T.
PMID: 42970107 [PubMed - as supplied by publisher]


Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: A Single-institution Retrospective Study.
Cancer Diagn Progn
Katano A, Yamashita H.
PMID: 42968802 [PubMed]


Evaluation of the efficacy and safety of different cycles of neoadjuvant chemotherapy combined with immunotherapy in locally advanced esophageal squamous cell carcinoma: a multi-center, real-world study.
World J Surg Oncol
Lv H, Wang Z, Su C, Wang H, Chen B, Gai C, Liu Y, Ding W, Wang M, Sun K, Zhang F, Zhu Y, Li Z, Tian Z.
PMID: 42968170 [PubMed - indexed for MEDLINE]


Survival outcomes of treatment strategies for cTanyN3M0 esophageal cancer: A nationwide population-based study.
Radiother Oncol
Hafkamp CJH, Geijsen ED, van Laarhoven HWM, Derks S, Bennink RJ, Verhoeven RHA, Meijer SL, Gisbertz SS, van Berge Henegouwen MI, Olthof PB, van der Veen A, van Rossum PSN.
PMID: 42967538 [PubMed - as supplied by publisher]


Elevated UBE2L6 Expression Predicts Poor Prognosis and Is Associated With Fatty Acid Metabolic Remodeling in Esophageal Cancer.
Mol Carcinog
Yao MJ, Wen ML, Ma MJ, Zhang MR, Hu MX, Zhao MC, Mu MB.
PMID: 42967324 [PubMed - as supplied by publisher]


Integrative Genetic and Functional Analysis Identifies the Asparagine-SLC38A2 Axis in Esophageal Squamous Cell Carcinoma.
Mol Carcinog
Ma J, Wu Y, Luo Y, Feng J, Guo W, Chang J.
PMID: 42967322 [PubMed - as supplied by publisher]


Histology-dependent coupling of TERT to the proliferation programme statistically accounts for much of the between-cohort heterogeneity in DNMT3B-TERT co-expression in oesophageal carcinoma: a 27-cohort meta-analysis and pan-cancer re-analysis.
Funct Integr Genomics
Khorrami M, Parvaresh E, Asadi J, Tatar M.
PMID: 42965673 [PubMed - indexed for MEDLINE]


The synergistic potential of combining PD-1/PD-L1 inhibitors with conventional therapies in esophageal squamous cell carcinoma.
Front Pharmacol
Li R, Heng Z, Cheng X.
PMID: 42964272 [PubMed]


Primary Liver Cancer and Other Malignancies in Alcohol Use Disorder and Alcohol-Associated Liver Disease.
Liver Int
Pizarro G, Alcayaga B, Rama K, González-Montero J, Arrese M, Arab JP, Díaz LA.
PMID: 42963959 [PubMed - indexed for MEDLINE]


Cancer in Seychelles: A Population-Based Study on Incidence, Trends and Stage at Diagnosis (2005-2024).
Int J Cancer
Finesse A, Mondon J, Shroff E, Gedeon J, Louange M, Parkin DM.
PMID: 42963954 [PubMed - as supplied by publisher]


Protocol for a multicenter prospective phase II trial of adjuvant tislelizumab combined with S-1 in subjects with residual primary lesions and node-negative esophageal squamous cell carcinoma (PPIO-008).
Future Oncol
Wang YJ, Chen X, Xie XF, Li CF, Bao T, He XD, Li KK, Pu XS, He Y, Guo W.
PMID: 42961934 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 40028    Page 1 de 2002  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1